Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-26T17:20:30.587Z Has data issue: false hasContentIssue false
  • English
  • Français

Regional audit of depot neuroleptic usage in adults with learning disabilities

Published online by Cambridge University Press:  02 January 2018

Shaun Gravestock
Shaun Gravestock*
Affiliation:
Division of Psychiatry UMDS Guy's Hospital, London; Learning Disabilities, Northgate Hospital, Morpeth Northumberland NE61 3BP
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A previous survey (Gravestock, 1996) assessed factors associated with depot neuroleptic usage in 79 adults with learning disabilities using mainly community-based services. The data informed consensus standard setting and this audit focusing on 32 out of 79 original subjects. At two year follow-up, five subjects had been withdrawn from depots; there was a significant (P < 0.001) reduction in subjects' median depot dosage and reduced concomitant usage of oral neuroleptics and anticholinergics. The importance of completing the audit cycle and other psychotropic medication monitoring studies in community learning disabilities services are discussed.

Type
Audit
Information
Psychiatric Bulletin , Volume 20 , Issue 5 , May 1996 , pp. 289 - 291
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1996

References

Aman, M. G. (1987) Overview of pharmacotherapy: current status and future directions. Journal of Mental Deficiency Research, 31, 121–130.Google Scholar
British Medical Association & The Pharmaceutical Society (1993) British National Formulary (BNF), No. 26. London: BMA & Pharmaceutical Society.Google Scholar
Clarke, D. J., Kelley, S., Thinn, K., et al (1990) Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and epilepsy in three residential settings. Journal of Mental Deficiency Research, 34, 385–395.Google Scholar
Craft, M. J. & Schiff, A. A. (1980) Psychiatric disturbance in mentally handicapped patients. British Journal of Psychiatry, 137, 250–255.Google Scholar
Crammer, J. & Eccleston, D. (1989) A survey of the use of depot neuroleptics in a whole region. Psychiatric Bulletin, 13, 517–520.Google Scholar
Curran, J. & Hollins, S. (1994) Consent to medical treatment and people with learning disability. Psychiatric Bulletin, 18, 691–693.CrossRefGoogle Scholar
Fraser, W. & Nolan, M. (1994) Psychiatric disorder in mental retardation. In Mental Health in Mental Retardation (ed. Bouras, N.). pp. 79–92. Cambridge: Cambridge University Press.Google Scholar
Gravestock, S. (1994) Quality assurance for adults with mental retardation and mental health needs. In Mental Health in Mental Retardation (ed. Bouras, N.), pp. 319–327. Cambridge: Cambridge University Press.Google Scholar
Gravestock, S. (1996) Depot neuroleptic usage in adults with learning disabilities. Journal of Intellectual Disability Research. 40, 17–23.Google Scholar
Harvey, R. J. & Cooray, S. E. (1993) Neuroleptic usage in a community mental handicap unit. Psychiatric Bulletin, 17, 657–660.Google Scholar
Kohen, D., Mathew, G. & Fernando, L. (1993) Survey of psychotropic medication: usage in a large mental handicap hospital. Psychiatric Bulletin, 17, 137–139.Google Scholar
Manchester, D. (1993) Neuroleptics, learning disability and the community: some history and mystery. British Medical Journal 307, 184–187.Google Scholar
SAS Institute (1989) SAS/STAT User's Guide, Version 6 (4th edn. Vol. 1). Cary NC, USA: SAS Institute.Google Scholar
Thinn, K., Clarke, D. J. & Corbett, J. A. (1990) Psychotropic drugs and mental retardation: 2. A comparison of psychoactive drug use before and after discharge from hospital to community. Journal of Mental Deficiency Research, 34, 397–407.Google Scholar
Wressell, S. E., Tyrer, S. P. & Berney, T. P. (1990) Reduction in antipsychotic drug dosage in mentally handicapped patients: a hospital study. British Journal of Psychiatry, 157, 101–106.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.